Trials / Conditions / HPV 16 Positive Oropharyngeal Tumors (OPC)
HPV 16 Positive Oropharyngeal Tumors (OPC)
3 registered clinical trials studyying HPV 16 Positive Oropharyngeal Tumors (OPC) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs NCT07418034 | University of Maryland, Baltimore | Phase 2 |
| Recruiting | Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatme NCT07209189 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Unknown | New Prognostic and Predictive Biomarkers for HPV-associated Oropharyngeal Cancer NCT06097936 | Regina Elena Cancer Institute | — |